Recent Updates
Recently added Catalysts
ECOR Positive Sentiment

electroCore to Participate in the Healthcare Virtual Conference Presented by Maxim Group LLC

Key Takeaway: electroCore, Inc. announced its participation in the Healthcare Virtual Conference Part II, scheduled for June 21, 2023. CEO Dan Goldberger will present at the event hosted by Maxim Group LLC and M-Vest. The company, specializing in bioelectronic medicine and wellness, aims to improve health using its non-invasive vagus nerve stimulation technology. The conference represents a strategic opportunity for electroCore to connect with potential investors and stakeholders in the healthcare sector.
Price reaction · baseline $4.37 (2023-06-13 close) · hit after-hours · clean, no other ECOR news in the window
day 0 close
+1.1%
day 1
+2.3%
day 3
0%

Market Sentiment Analysis

POSITIVE FACTORS

  • Company CEO will present at a prominent healthcare virtual conference.
  • Focus on bioelectronic medicine demonstrates innovative approach to health.
  • Participation in the conference may enhance visibility among investors.

BiopharmaWatch Analysis

From our catalyst data and publicly available data · not financial advice
Cash runway
~7 mo
High dilution risk
Lead asset
GammaCore
Phase 2 · Chronic Cluster Headache

Full Press Release Details

ROCKAWAY, N.J., June 14, 2023 (GLOBE NEWSWIRE) -- electroCore, Inc. (Nasdaq: ECOR), a commercial-stage bioelectronic medicine and wellness company, announced today that Company CEO, Dan Goldberger, will present at the Healthcare Virtual Conference Part II, presented by Maxim Group LLC and hosted by M-Vest.
Healthcare Virtual Conference Presented by Maxim:
Date: Wednesday, June 21, 2023
Event: Company Discussion
Virtual viewers: register to join M-Vest here
For more information regarding the conference and to register to watch the presentation live, please visit the conference page here.
About electroCore, Inc.
electroCore, Inc. is a commercial stage bioelectronic medicine and wellness company dedicated to improving health through its non-invasive vagus nerve stimulation (“nVNS”) technology platform. Our focus is the commercialization of medical devices for the management and treatment of certain medical conditions and consumer product offerings utilizing nVNS to promote general wellbeing and human performance in the United States and select overseas markets.
For more information, visit www.electrocore.com.

Frequently Asked Questions

What will Dan Goldberger present at the conference?

Dan Goldberger will discuss electroCore, Inc. at the Healthcare Virtual Conference.

When is the Healthcare Virtual Conference scheduled?

The conference is scheduled for Wednesday, June 21, 2023.

How can I register for the virtual conference?

To register for the conference, visit the M-Vest registration page.

What technology does electroCore specialize in?

electroCore specializes in non-invasive vagus nerve stimulation (nVNS) technology.

What is the goal of electroCore's products?

The goal is to manage medical conditions and promote overall wellbeing.

Last updated: Jun 14, 2023